---
title: "A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader"
description: "QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines."
url: https://qbdgroup.com/en/case-studies/linguistic-review-support-for-a-global-pharma-leader
type: "Case study"
language: en
published: 2025-04-01
publisher: "QbD Group"
citation: "QbD Group, \"A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader\", https://qbdgroup.com/en/case-studies/linguistic-review-support-for-a-global-pharma-leader"
---
# A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader
> QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.

As **one of the world’s leading pharmaceutical companies**, our client develops and distributes innovative medicinal products that improve patient care.

Operating across diverse markets, they **must ensure that Product Information (PI) remains clear, precise, and compliant in multiple languages** while meeting stringent regulatory requirements. With ever-evolving guidelines and tight submission deadlines, maintaining compliance across 25 EU/EEA languages is a major operational challenge.

## Challenge

### Regulatory & linguistic complexity

Since 2010, QbD Group has partnered with this pharmaceutical leader to **manage the intricate post-approval linguistic review process for a family of medicinal products**. The complexity of coordinating multiple translations, ensuring alignment with QRD guidelines, and adhering to EMA procedures created significant challenges, including:

- Managing PI updates across 25 EU/EEA languages while meeting strict submission deadlines.
- Ensuring accuracy and consistency in translations across multiple regulatory frameworks.
- Implementing an efficient workflow to standardize processes and reduce errors.

[Discover our approach](https://qbdgroup.com/en/case-studies/linguistic-review-support-for-a-global-pharma-leader#approach)

## Approach

### Streamlining the linguistic review process

To ensure efficiency and accuracy, QbD Group developed a **structured, standardized approach** to translation management, quality control, and submission coordination. Our key strategies include:

- Early preparation of the **English PI** to align with QRD guidelines before MAA or post-approval submissions.
- Clear, **well-defined processes** supported by **specialized software tools** to ensure precision and consistency.
- A proactive workflow to meet strict regulatory deadlines without compromising quality.

[Read more about the results](https://qbdgroup.com/en/case-studies/linguistic-review-support-for-a-global-pharma-leader#results)

## Results

### Delivering regulatory excellence

With deep **expertise in EMA procedures**, QbD Group has successfully managed over 250 linguistic review procedures, ensuring:

- High-quality submissions that meet stringent regulatory requirements.
- Standardized processes and automation for enhanced accuracy and efficiency.
- A long-standing partnership built on trust, expertise, and proven results.

By combining regulatory know-how with an efficient, structured approach, QbD Group continues to support our client in maintaining compliance and ensuring clear, accurate product information across multiple markets.

[Also need support?](https://qbdgroup.com/en/case-studies/linguistic-review-support-for-a-global-pharma-leader)
---
Source: https://qbdgroup.com/en/case-studies/linguistic-review-support-for-a-global-pharma-leader — © QbD Group. Quote freely with attribution and a link back.